News for 'sun-pharma'

Sun Pharma to invest Rs 450 cr for expansion

Sun Pharma to invest Rs 450 cr for expansion

Rediff.com30 May 2011

Israel-based Taro pharmaceutical industries became Sun Pharma's subsidiary on September 20, 2010.

Fresh US tariffs unnerve investors; Sensex down 380 points

Fresh US tariffs unnerve investors; Sensex down 380 points

Rediff.com9 Apr 2025

State Bank of India, Tech Mahindra, Larsen & Toubro, Tata Steel, Sun Pharma, Infosys, HCL Tech, Axis Bank, Tata Consultancy Services and NTPC were among the biggest laggards among Sensex shares. Nestle, Hindustan Unilever, Titan, Power Grid, UltraTech Cement and ITC were among the gainers.

Sensex sinks 425 points dragged by auto stocks, foreign fund outflows

Sensex sinks 425 points dragged by auto stocks, foreign fund outflows

Rediff.com21 Feb 2025

Equity benchmark indices Sensex and Nifty ended lower on Friday, dragged by auto stocks and relentless foreign fund outflows. Weak US markets and tariff threats also dented investor sentiment. The 30-share BSE benchmark Sensex dropped 424.90 points or 0.56 per cent to settle at 75,311.06.

Sensex pares intra-day high to end up 598 points

Sensex pares intra-day high to end up 598 points

Rediff.com3 Dec 2024

From the 30-share Sensex pack, Adani Ports surged nearly 6 per cent. NTPC, Axis Bank, State Bank of India, Larsen & Toubro, UltraTech Cement, Tata Motors, HDFC Bank and Reliance Industries were the other big gainers. Bharti Airtel, ITC, Sun Pharma, Asian Paints and Kotak Mahindra Bank were the laggards.

Why Sun Pharma stock will remain under pressure

Why Sun Pharma stock will remain under pressure

Rediff.com24 Dec 2019

The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality drug payoffs.

Sun Pharma unit recalls mutiple lots of capsules from US

Sun Pharma unit recalls mutiple lots of capsules from US

Rediff.com15 Aug 2014

The recalled drug bottles were distributed by Caraco Pharmaceutical Laboratories, Ltd in the US while manufactured in India by Sun Pharmaceutical Industries Ltd.

Sensex, Nifty surge nearly 2% on buying in financial, IT stocks

Sensex, Nifty surge nearly 2% on buying in financial, IT stocks

Rediff.com2 Jan 2025

From 30 Sensex shares, Bajaj Finserv jumped nearly 8 per cent while Bajaj Finance soared over 6 per cent. Maruti, Titan, Mahindra, Mahindra & Mahindra, Infosys, HCL Tech, Zomato, UltraTech Cement and Kotak Mahindra Bank were the other major gainers. Sun Pharma emerged as the only laggard.

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Rediff.com6 Dec 2018

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

Markets end marginally lower in volatile trade

Markets end marginally lower in volatile trade

Rediff.com19 Feb 2025

From the Sensex pack, Tata Consultancy Services and Infosys fell over 2 per cent each. Hindustan Unilever, Bharti Airtel, Sun Pharma, Power Grid, Bajaj Finserv, HCL Tech, Mahindra & Mahindra, and Tech Mahindra were also among the laggards. Among the gainers, Zomato jumped nearly 5 per cent. Larsen & Toubro, Axis Bank, ICICI Bank, IndusInd Bank and Kotak Mahindra Bank were also among the gainers.

Markets open higher ahead of Budget presentation

Markets open higher ahead of Budget presentation

Rediff.com1 Feb 2025

From the 30-share blue-chip pack, ITC Hotels, IndusInd Bank, Mahindra & Mahindra, Sun Pharma, UltraTech Cement and NTPC were among the biggest gainers. Titan, Kotak Mahindra Bank, Nestle, Asian Paints, HCL Tech and ICICI Bank were among the laggards.

Markets crash 1.6%; Sensex tanked 1,258 points

Markets crash 1.6%; Sensex tanked 1,258 points

Rediff.com6 Jan 2025

From the 30-share blue-chip pack, Tata Steel, NTPC, Kotak Mahindra Bank, IndusInd Bank, Power Grid, Zomato, Adani Ports, Asian Paints, Mahindra & Mahindra and Reliance Industries were among the biggest laggards. Titan and Sun Pharma were the only gainers.

Ranbaxy woes continue to dog Sun Pharma

Ranbaxy woes continue to dog Sun Pharma

Rediff.com29 Oct 2015

The recalled drugs were manufactured and distributed in the US by Ohm Laboratories.

SRK, Sachin Hug At Swearing In

SRK, Sachin Hug At Swearing In

Rediff.com5 Dec 2024

Mukesh Ambani, accompanied by younger son Anant and younger daughter-in-law Radhika Merchant Ambani, were among the many celebrities who attended Devendra Fadnavis' swearing in at Azad Maidan on Thursday afternoon.

Sun Pharma rejects Taro's offer of $15 per share

Sun Pharma rejects Taro's offer of $15 per share

Rediff.com8 Jan 2009

Sun had rejected Taro's offer of conducting a shareholder referendum at any price of its (Sun's) choosing to settle the issue, besides offering other options, saying it was an attempt to sidestep from the real issues.

Markets end in red on surging crude prices, FII outflows

Markets end in red on surging crude prices, FII outflows

Rediff.com10 Jan 2025

From the 30-share blue-chip pack, IndusInd Bank, NTPC, UltraTech Cement, Sun Pharma, Axis Bank, State Bank of India, Tata Steel, Power Grid, Adani Ports and Kotak Mahindra Bank were among the major laggards. Tata Consultancy Services jumped nearly 6 per cent after the IT services company reported an 11.95 per cent jump in the December quarter net profit to Rs 12,380 crore. Tech Mahindra, HCL Tech, Infosys and Bajaj Finserv were the other big gainers.

Relentless FII selling hits market sentiments; Sensex down 200 points

Relentless FII selling hits market sentiments; Sensex down 200 points

Rediff.com14 Feb 2025

From the 30-share blue-chip pack, Adani Ports dropped over 4 per cent. UltraTech Cement, Sun Pharma, IndusInd Bank, NTPC and Tata Steel were also the among the laggards. Nestle, ICICI Bank, Infosys, Tata Consultancy Services and HCL Tech were among the gainers.

SC asks Andhra court to decide on Ranbaxy-Sun Pharma merger

SC asks Andhra court to decide on Ranbaxy-Sun Pharma merger

Rediff.com21 May 2014

The Supreme Court has asked the Andhra Pradesh High Court to take a decision within two days on a plea challenging merger of Sun Pharmaceutical with Ranbaxy.

How Much Have MFs Invested In HDFC Bank?

How Much Have MFs Invested In HDFC Bank?

Rediff.com16 Aug 2024

With a deployment of Rs 2,720 crore in July, MFs' total investment in HDFC Bank in calendar year 2024 (till now) surged to Rs 48,820 crore.

Markets join global selloff; Sensex sinks below 80k

Markets join global selloff; Sensex sinks below 80k

Rediff.com19 Dec 2024

Equity benchmark Sensex on Thursday plunged about 965 points to crash below the 80,000 level due to heavy selling in global equities after the US Federal Reserve signalled fewer rate cuts next year. Besides, deep losses in consumer durables, banking and IT stocks amid foreign fund outflows added to the gloom, analysts said.

GDP growth projection spooks markets; Sensex down 51 points

GDP growth projection spooks markets; Sensex down 51 points

Rediff.com8 Jan 2025

From the 30-share blue-chip pack, Adani Ports, UltraTech Cement, Larsen & Toubro, Sun Pharma, HDFC Bank, ICICI Bank, NTPC and State Bank of India were the major laggards. Tata Consultancy Services, Reliance Industries, ITC, Asian Paints, HCL Tech and Maruti were among the gainers.

Adani's clarification on bribery charges lifts markets

Adani's clarification on bribery charges lifts markets

Rediff.com27 Nov 2024

From the 30-share Sensex pack, Adani Ports surged 6 per cent. NTPC, HDFC Bank, Bajaj Finance, Maruti and Axis Bank were among the other gainers. In contrast, Titan, State Bank of India, Asian Paints, Tata Consultancy Services, HCL Tech, Sun Pharma, IndusInd Bank and ICICI Bank were among the laggards.

Trump's tariff threats spooks markets; Sensex down 106 points

Trump's tariff threats spooks markets; Sensex down 106 points

Rediff.com26 Nov 2024

Trump's tariff threats spooks markets; Sensex down 106 points

Sensex, Nifty rise on buying in bank stocks, positive global cues

Sensex, Nifty rise on buying in bank stocks, positive global cues

Rediff.com29 Oct 2024

From the 30 Sensex pack, State Bank of India jumped 5 per cent, followed by ICICI Bank, Bajaj Finserv, NTPC, Adani Ports, Bajaj Finance and Larsen & Toubro. In contrast, Maruti, Tata Motors, Sun Pharma, Bharti Airtel, IndusInd Bank and Mahindra & Mahindra were among the laggards.

Sun Pharma gets US FTC nod for Taro open offer

Sun Pharma gets US FTC nod for Taro open offer

Rediff.com14 Aug 2008

In a filing to the Bombay Stock Exchange, Sun Pharma said the US Federal Trade Commission (FTC) has granted early termination of the anti-trust waiting period for the previously announced tender offer by its subsidiary Alkaloida Chemical Company Exclusive Group Ltd. Last month the Mumbai-based firm had launched an open offer at a price of $7.75 per share to acquire all outstanding shares of Taro, including all of the founders' shares.

Sensex tanks 836 points; Nifty ends at 24,199

Sensex tanks 836 points; Nifty ends at 24,199

Rediff.com7 Nov 2024

From the 30-share Sensex pack, Tata Motors, Tech Mahindra, UltraTech Cement, JSW Steel, Sun Pharma, Asian Paints, IndusInd Bank and ICICI Bank were the major losers. State Bank of India emerged as the only gainer from the pack.

Sensex jumps 603 points; ICICI Bank climbs 3%

Sensex jumps 603 points; ICICI Bank climbs 3%

Rediff.com28 Oct 2024

From the 30 Sensex pack, ICICI Bank climbed 3 per cent after the private sector lender posted a 14.5 per cent growth in standalone profit to Rs 11,746 crore for the second quarter ended September 2024. JSW Steel, Mahindra & Mahindra, Adani Ports, Tata Steel, Sun Pharma, Hindustan Unilever, Tata Motors and State Bank of India were the other big gainers from the pack.

Markets slump 1%; Sensex tumbled 821 points

Markets slump 1%; Sensex tumbled 821 points

Rediff.com12 Nov 2024

From the 30-share Sensex pack, NTPC, Asian Paints, HDFC Bank, State Bank of India, Tata Motors, JSW Steel, Maruti and Power Grid were among the major laggards. On the other hand, Sun Pharma, Infosys and ICICI Bank were the gainers.

Lower input costs may aid pharma firms' Q2 margins

Lower input costs may aid pharma firms' Q2 margins

Rediff.com21 Oct 2024

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and amortisation) margins are anticipated to improve by about 110 basis points. Ebitda improvement will be led by lower input costs because prices of active pharmaceutical ingredients (APIs) are 5-15 per cent lower year-on-year (Y-o-Y). Axis Capital said sales growth would be around 10 per cent, of which growth in the India market would be 11 per cent or so.

Spike in crude oil price, FII outflows spook markets

Spike in crude oil price, FII outflows spook markets

Rediff.com13 Jan 2025

From the 30-share blue-chip pack, Zomato cracked nearly 7 per cent. Power Grid, Adani Ports, Tata Steel, NTPC, Tata Motors, Tech Mahindra, Mahindra & Mahindra, Asian Paints, Sun Pharma and UltraTech Cement were the other major laggards. In contrast, Axis Bank, Hindustan Unilever, Tata Consultancy Services and IndusInd Bank were the gainers.

FPI selling spree, IT stocks dampen investor sentiment

FPI selling spree, IT stocks dampen investor sentiment

Rediff.com18 Nov 2024

From the 30-share Sensex pack, Tata Consultancy Services, Infosys, NTPC, HCL Technologies, Axis Bank, Tech Mahindra, Bajaj Finserv, Sun Pharma, IndusInd Bank and Reliance Industries were the major laggards. Tata Steel, Hindustan Unilever, Mahindra & Mahindra, Nestle and State Bank of India were among the gainers.

Sensex tanks 663 points; IndusInd Bank plunged over 18%

Sensex tanks 663 points; IndusInd Bank plunged over 18%

Rediff.com25 Oct 2024

From the 30 Sensex pack, IndusInd Bank plunged over 18.50 per cent after the firm reported a 40 per cent decline in September quarter net profit at Rs 1,331 crore, pulled down by concerns over its asset quality. Mahindra & Mahindra, Larsen & Toubro, NTPC, Adani Ports, Tata Steel, Maruti, Bajaj Finance and Titan were also among the laggards.

Sensex tumbles 553 points on selling in IT stocks

Sensex tumbles 553 points on selling in IT stocks

Rediff.com31 Oct 2024

From the 30-share Sensex pack, Tech Mahindra, HCL Technologies, Tata Consultancy Services, Asian Paints, Infosys and Maruti Suzuki were the biggest laggards.

Investors become poorer by Rs 5.29 lakh cr as markets slump

Investors become poorer by Rs 5.29 lakh cr as markets slump

Rediff.com12 Nov 2024

A sharp fall in the equity market made investors poorer by Rs 5.29 lakh crore on Tuesday when the BSE benchmark Sensex tumbled over 800 points. A host of negative triggers -- muted quarterly earnings, continuous foreign fund outflows and weak trends in Asian and European markets -- dragged the benchmark indices lower. The BSE benchmark gauge tumbled 820.97 points or 1.03 per cent to settle at 78,675.18.

Investors lose Rs 7.15 lakh cr as markets slump

Investors lose Rs 7.15 lakh cr as markets slump

Rediff.com25 Oct 2024

Investors' wealth eroded by a whopping Rs 7.15 lakh crore during the morning trade on Friday as equity markets tumbled, driven by sharp fall in IndusInd Bank shares and unabated foreign fund outflows. The BSE Sensex tanked 708.69 points to 79,356.47 and the NSE Nifty plunged 286.35 points to 24,113.05. Tracking the weak trend in equities, the market capitalisation of BSE-listed firms tumbled Rs 715,739.19 crore to Rs 4,36,63,565.73 crore ($5.19 trillion) during the morning trade.

Rs 24.69 lakh cr of investors' wealth wiped out in 4 days

Rs 24.69 lakh cr of investors' wealth wiped out in 4 days

Rediff.com13 Jan 2025

Investors lost Rs 24.69 lakh crore in market valuation in the last four days of severe drubbing in the equity market. Spike in global crude prices, unabated foreign fund outflows, a strong US jobs data diminishing early rate cut expectations, and the rupee logging its steepest single-day fall in nearly two years dampened investors' sentiment.

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

Rediff.com5 Aug 2020

Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease.

Sensex drops 138 points on foreign fund outflow

Sensex drops 138 points on foreign fund outflow

Rediff.com23 Oct 2024

Sensex drops 138 points on foreign fund outflow

Sensex tanks 942 pts, Nifty plunges below 24K

Sensex tanks 942 pts, Nifty plunges below 24K

Rediff.com4 Nov 2024

From the 30-share Sensex pack, Sun Pharma, Reliance Industries, Infosys, Tata Motors, Infosys, Titan, Maruti and NTPC were among the major laggards. Mahindra & Mahindra, Tech Mahindra, HCL Technologies and IndusInd Bank were the gainers.

Markets fall for 6th straight session; Sun Pharma dips 2%

Markets fall for 6th straight session; Sun Pharma dips 2%

Rediff.com21 Dec 2016

Sun Pharma dipped 2% to Rs 615 on the BSE, its lowest level since November 9, 2016

Markets recovery makes investors richer by Rs 4.21 lakh cr

Markets recovery makes investors richer by Rs 4.21 lakh cr

Rediff.com28 Oct 2024

Investors' wealth on Monday surged Rs 4.21 lakh crore as markets bounced back after five days of fall. The BSE Sensex jumped 602.75 points or 0.76 per cent to settle at 80,005.04. During the day, it surged 1,137.52 points or 1.43 per cent to 80,539.81.